RPAM
SGMO

Rhenman & Partners Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Rhenman & Partners Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-314,157
Closed -$534K – 92
2023
Q1 		$534K Sell
314,157
-505,843
-62% -$1.44M 0.06% 87
2022
Q4 		$2.57M Hold
820,000
– – 0.27% 77
2022
Q3 		$3.6M Buy
820,000
+120,000
+17% +$616K 0.38% 71
2022
Q2 		$2.9M Sell
700,000
-61,429
-8% -$266K 0.33% 67
2022
Q1 		$4.42M Sell
761,429
-3,571
-0.5% -$21.2K 0.44% 66
2021
Q4 		$5.97M Hold
765,000
– – 0.4% 64
2021
Q3 		$6.89M Hold
765,000
– – 0.48% 64
2021
Q2 		$9.16M Hold
765,000
– – 0.62% 58
2021
Q1 		$9.59M Sell
765,000
-56,888
-7% -$767K 0.67% 49
2020
Q4 		$12.8M Buy
821,888
+146,888
+22% +$1.72M 1.05% 40
2020
Q3 		$6.38M Hold
675,000
– – 0.57% 57
2020
Q2 		$6.05M Sell
675,000
-25,000
-4% -$232K 0.65% 54
2020
Q1 		$4.46M Hold
700,000
– – 0.62% 55
2019
Q4 		$5.86M Sell
700,000
-34,811
-5% -$320K 0.64% 60
2019
Q3 		$6.65M Sell
734,811
-59,146
-7% -$664K 0.83% 46
2019
Q2 		$8.55M Sell
793,957
-50,000
-6% -$532K 0.94% 45
2019
Q1 		$8.05M Sell
843,957
-260,000
-24% -$2.66M 0.94% 49
2018
Q4 		$12.7M Sell
1,103,957
-93,400
-8% -$1.16M 1.45% 35
2018
Q3 		$20.3M Buy
1,197,357
+145,424
+14% +$2.21M 2.03% 16
2018
Q2 		$14.9M Buy
1,051,933
+796,140
+311% +$13.2M 1.53% 29
2018
Q1 		$4.86M Hold
255,793
– – 0.6% 57
2017
Q4 		$4.2M Buy
+255,793
New +$3.81M 0.57% 62

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rhenman & Partners Asset Management's SGMO Position: Q2 2023 in Review

Rhenman & Partners Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 314,157 shares — an estimated $534K sold.

Rhenman & Partners Asset Management first reported a position in SGMO in Q4 2017 and held it in 22 quarters. The position peaked at $20.3M in Q3 2018. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Rhenman & Partners Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 314,157 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $534K.
  • Rhenman & Partners Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 22 quarters.
  • Rhenman & Partners Asset Management's SANGAMO THERAPEUTICS INC position peaked at $20.3M in Q3 2018.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.